Fraud Blocker

Euglycemic Diabetic Ketoacidosis: A Case Study

Kevin Freels, MD DKA and SGLT-2 inhibitors One of the greatest aspects of medicine that I enjoy is a continual process of learning. We must continue to grow in our profession, seeking knowledge and experience as much as possible. One such incident occurred recently while on shift… and talk about being a little late to …

Read more

What’s your mission?

Bunnany Pekar, CRNA, ARNP In honor of the Reverend Dr. Martin Luther King, Jr An Immigrants Story Please allow me to share my perspective on why I chose to travel across the world to provide medical care to people I do not know. But first, I am going to provide you with a little background …

Read more

Syncope (2007)

Inclusion: Adult Exclusion: Children or for patients whom episode of syncope is thought to be secondary to another disease process Level A: History and PE consistent with heart failure help identify patients at high risk for an adverse outcome. Standard 12-lead ECG Level B: High risk of AE: Older age, structural heart disease, history of CAD Low risk of …

Read more

Neuroimaging and decision making in TBI (2008)

Inclusion: Non-penetrating trauma to the head Presentation to ED within 24 hours of injury GCS 14 or 15 on initial evaluation in ED Age ≥ 16 Exclusion: Penetrating trauma Patients with multi-system trauma GCS < 14 on initial evaluation in the ED Age < 16 Level A: A noncontrast head CT indicate in head trauma …

Read more

Prescribing Opioids (2012)

Inclusion: Adult with acute non-cancer pain or acute exacerbation of chronic non-cancer pain Exclusion: Long term care of patients w cancer or chronic non-cancer pain Level A: Level B: Short-acting opioids such as oxycodone or hydrocodone for short term relief of acute musculoskeletal pain ‘Level C: Use of state prescription monitoring program may help identify patients at …

Read more

tPA for Acute Ischemic Stroke (2015)

Inclusion: Adult patients presenting to ED with acute ischemic stroke Exclusion: Children < 18 years Level A: None. Level B: Offer IV tPA to acute ischemic stroke patients who meet NINDS inclusion/exclusion criteria and can be treated within 3 hours after symptom onset. Consider increased risk of symptomatic intracranial hemorrhage in decision to administer tPA. (May consider …

Read more